The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Series A | Alive

Total Raised


Last Raised

$54M | 22 yrs ago

About Vector Development

Vector Development is a development firm.

Vector Development Headquarter Location

4350 North Fairfax Drive Suite 350

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Vector Development News

Viral Vector Development Market to Reach USD 177.7 Billion by 2026, Exhibiting a CAGR of 16.5% in The Forecast Period 2022-2032

May 12, 2022

Search jobs 12-May-2022 Viral Vector Development Market to Reach USD 177.7 Billion by 2026, Exhibiting a CAGR of 16.5% in The Forecast Period 2022-2032 According to a recent study done by FMI, the  ePharmacy market  is expected to reach US$ 329.83 billion by 2032, up from US$ 69.8 billion in 2021, expanding at a high CAGR of 16.4%. This study explains how the ePharmacy market is directly proportional to the increasing penetration of internet-based pharmacy in the world market coupled with rising awareness of epharmacy amongst the common masses. Easy purchasing, availability of a range of medications and quality medical services on the internet is holding up the customer preferences and shifting them to e pharmacy platforms. Get the Report Sample @ A large number of smartphone sales and spreading awareness about the concept of epharmacy. The rising geriatric population base that suffers from chronic diseases and staying in remote areas increases sales through ePharmacy. This also affects the e-pharmacy market in India as sales of smartphones are increasing here as well. Lucrative offers, high discounts, and easy accessibility help end users navigate and order medicines easily, part of the ePharmacy business model. This drives the global market and increases sales through epharmacy. With the increasing accessibility of e-commerce and the online industry, the availability of medicines is also rising as multiple vendors (B2C and B2C) are getting a space online. This provides these vendors with a better space to sell their products. “The major challenge with ePharmacy market is rising number of illegal vendors online that decrease the credibility of online sources. Also, risks associated with counterfeit drugs are downgrading the marketing. To prevent these illegal vendors, e pharmacy regulations are there in every country.” Key Takeaway The government initiatives and e pharmacy regulations support and control digital technology to improve the space and its functionality. Several industry players get benefitted from the government awareness programs. North America dominates the market as it holds more than 35% of the global epharmacy market. The factor behind the excessive growth is the extreme internet penetration amongst the American population. epharmacy businesses design their product profile and marketing campaign with the prescription portal attached to it that makes customers interact with the website easily and upload the prescription without a hitch. 63% of the world’s population is on the internet and interacts with eCommerce websites daily which directly proliferates the market growth. The global epharmacy market is segmented by product type that is further segmented into OTC products and prescription medicines. The biggest segment by the product type category is OTC products. These products are in high demand because of the easy access and low hassle processes. Competitive Landscape The Walgreen Company dominates the global ePharmacy market, Express Scripts Holding, CVS Health, DocMorris, Giant Eagle, Wal-Mart Stores, OptumRx, PharmEasy, 1mg and Netmeds. These companies are adopting new digital channels and processes to increase their stronghold in the ePharmacy market. In 2021, PharmEasy initiated the takeover of MedLife to expand the deliverables and stronghold in India. Lately, Express scripts have launched a new program named Express Scripts Parachute Rx that offer price discounts on multiple products. Ask for the TOC of this Report with figures @ About Future Market Insights (FMI) Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years Contact Us:

  • When was Vector Development founded?

    Vector Development was founded in 2000.

  • What is Vector Development's latest funding round?

    Vector Development's latest funding round is Series A.

  • How much did Vector Development raise?

    Vector Development raised a total of $54M.

  • Who are the investors of Vector Development?

    Investors of Vector Development include Warburg Pincus, AEA Investors and Deutsche Bank.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.